These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31717517)

  • 1. Distinct Subcellular Compartments of Dendritic Cells Used for Cross-Presentation.
    Imai J; Otani M; Sakai T
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are ERAD components involved in cross-presentation?
    Grotzke JE; Cresswell P
    Mol Immunol; 2015 Dec; 68(2 Pt A):112-5. PubMed ID: 26005101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation.
    Imai J; Otani M; Sakai T; Hatta S
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28872140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-presentation of exogenous antigens on MHC I molecules.
    Colbert JD; Cruz FM; Rock KL
    Curr Opin Immunol; 2020 Jun; 64():1-8. PubMed ID: 31927332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.
    Segura E; Villadangos JA
    Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells.
    Bougnères L; Helft J; Tiwari S; Vargas P; Chang BH; Chan L; Campisi L; Lauvau G; Hugues S; Kumar P; Kamphorst AO; Dumenil AM; Nussenzweig M; MacMicking JD; Amigorena S; Guermonprez P
    Immunity; 2009 Aug; 31(2):232-44. PubMed ID: 19699172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.
    Ackerman AL; Kyritsis C; Tampé R; Cresswell P
    Nat Immunol; 2005 Jan; 6(1):107-13. PubMed ID: 15592474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation.
    Guttman O; Le Thomas A; Marsters S; Lawrence DA; Gutgesell L; Zuazo-Gaztelu I; Harnoss JM; Haag SM; Murthy A; Strasser G; Modrusan Z; Wu T; Mellman I; Ashkenazi A
    J Cell Biol; 2022 Jun; 221(6):. PubMed ID: 35446348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
    Montealegre S; van Endert PM
    Front Immunol; 2018; 9():3098. PubMed ID: 30666258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways for antigen cross presentation.
    Guermonprez P; Amigorena S
    Springer Semin Immunopathol; 2005 Jan; 26(3):257-71. PubMed ID: 15592842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells.
    Imai J; Hasegawa H; Maruya M; Koyasu S; Yahara I
    Int Immunol; 2005 Jan; 17(1):45-53. PubMed ID: 15546887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
    Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P
    Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular recycling and cross-presentation by MHC class I molecules.
    van Endert P
    Immunol Rev; 2016 Jul; 272(1):80-96. PubMed ID: 27319344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-presentation by dendritic cells.
    Joffre OP; Segura E; Savina A; Amigorena S
    Nat Rev Immunol; 2012 Jul; 12(8):557-69. PubMed ID: 22790179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.
    Horrevorts SK; Duinkerken S; Bloem K; Secades P; Kalay H; Musters RJ; van Vliet SJ; García-Vallejo JJ; van Kooyk Y
    Front Immunol; 2018; 9():1231. PubMed ID: 29963041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.